American Vanguard Corporation Q4 FY2025 earnings call

CEO Dak Kay mentioned 2025 was challenging for ag sector but company made progress with business, operational, digital, and organizational initiatives. Hired quality colleagues, improved safety metrics, focused on new products and cost reduction. Rationalized Los Angeles manufacturing facility to save at least $4 million annually, moving volumes to Access Alabama to improve utilization. Relocating global headquarters from Newport Beach to Irvine to save half a million annually. Supply chain and logistics team decreased material costs and improved warehousing/freight expenses. Plan to launch 5 new products in North America in 2026 and at least 25 new products in North America by 2031. Appointed new chief commercial officer Mike DiPaola to be more responsive to customers

In 2025, the company generated sales of $515 million, down 6% from prior year. Adjusted EBITDA was $39.2 million, slightly better than prior year. International operations sales down 14% due to drought in Australia, channel inventory in Mexico; U.S. crop business sales similar to prior year; specialty sales up 10% driven by joint development agreement and mosquito vector solutions. Gross profit margin was 29% in 2025, OPEX as percentage of sales slightly decreased to 27%

Expect to generate adjusted EBITDA of 44 to 48 million in 2026 on sales of 530 to 550 million. Believe future earnings power is substantially higher, allowing debt paydown and investments for long-term growth. Plan to further decrease net working capital in 2026, with CapEx in $5 to $10 million range

Agricultural economy downturn since 2023, commodities still below historical normal levels. Distributors not restocking inventories. Farmer liquidity concern due to depressed commodity prices for several years. Geopolitical issues impacting growers' crop decisions. Prepay collections $50 million less in 2025 than 2024 due to competitor financial strain affecting channel prepay programs

Q: Mike Harrison asked about Q4 revenue and EBITDA shortfall, color on revenue drag and margin performance.

A: Domestic was due to U.S. crop METAM sales lower, potato acres and soil insecticides down, but herbicide Zalo had positive impact. Internationally due to drought in Australia and channel inventory in Mexico. Cost containment good in Q4.

Q: Rosemary Morbelli asked about $100 million from new products, details on products and timing.

A: New products primarily from insecticides and herbicides, defined as less than five years from launch. Midterm from around 2030-2031, takes around three years from idea to registration. Goal to reach 15% EBITDA margin long term, with 4%-6% compound annual growth rate in top-line and cost reduction